Regulatory Strategy

FDA Annual Device Registration Renewal: Deadlines, Fees, and the Cost of Missing the Window

By Andre D. Butler, Principal Consultant  ·  reviewed September 2026  ·  ← All Insights

FDA annual registration renewal — the October 1 to December 31 window, fees, and what happens if you miss it

Photo by Adam Tinworth on Unsplash

FDA Annual Establishment Registration Renewal: What Every Device Company Needs to Know Before December 31

Every year, medical device companies face a hard regulatory deadline that carries real operational consequences if missed: the annual renewal of FDA establishment registration. The renewal window opens October 1 and closes December 31. That is a 92-day window — and it moves fast, especially for lean teams juggling product launches, audits, and year-end planning.

This post breaks down exactly what is required, what it costs, and what happens to your business if you let the deadline slip.

The Legal Basis: Why Registration Is Not Optional

Under 21 CFR Part 807, domestic and foreign establishments that manufacture, prepare, propagate, compound, or process medical devices intended for U.S. commercial distribution are required to register with FDA and list their devices. This requirement applies to manufacturers, contract manufacturers, specification developers, repackagers, relabelers, and certain initial importers.

The statutory authority sits in Section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). FDA reinforced and modernized the process through the Medical Device User Fee Amendments (MDUFA) framework, which tied annual registration to user fee payment — meaning registration and fee submission are now inseparable.

There is no grace period. There is no extension mechanism built into the regulation. The window is October 1 through December 31, full stop.

How the Registration and Fee Process Works

Registration and device listing are completed through FDA's Unified Registration and Listing System (FURLS), accessed via the FDA Industry Systems portal. Here is the sequence every responsible regulatory team should follow:

  • Confirm your FEI number is active — Your Facility Establishment Identifier (FEI) must be in good standing before you can submit renewal.
  • Pay the annual establishment registration fee — For fiscal year 2025, the standard fee is $7,653 per establishment. Small businesses that qualify under FDA's definition (fewer than 500 employees and gross receipts or sales of $100 million or less) may be eligible for reduced fees — historically set at 50% of the standard rate. Always confirm the current year fee on FDA's official MDUFA fee schedule page, as amounts adjust annually.
  • Submit or confirm your device listing — Registration renewal does not automatically update your device listings. Under 21 CFR 807.20, listings must be updated within 30 days of any change in marketed devices. Use the renewal window as an opportunity to audit your listed devices against your actual portfolio.
  • Receive and retain your registration confirmation — Print or archive the updated registration certificate. Customers, distributors, and notified bodies will ask for it.

What Happens If You Miss the December 31 Deadline

This is where the stakes become operationally significant. Under 21 CFR 807.22, an establishment that fails to register or pay the required fee is considered to be operating in violation of the FD&C Act. The practical consequences cascade quickly:

  • Your devices become adulterated under 21 CFR 807.87 — Devices from an unregistered establishment are legally considered adulterated, making their distribution a prohibited act under Section 301 of the FD&C Act.
  • Import alerts for foreign establishments — FDA can place foreign establishments on import alert, resulting in automatic detention of shipments at the U.S. border — with no case-by-case review.
  • Domestic distribution holds — While FDA does not station inspectors at shipping docks, the compliance risk is real. During any subsequent inspection or audit, lapsed registration is an immediate red flag and likely Form 483 observation territory.
  • Customer and distributor contracts at risk — GPO agreements, hospital supply contracts, and distribution agreements routinely require current FDA registration as a condition of doing business. A lapsed registration can trigger breach of contract provisions.
  • 510(k) and PMA submissions impacted — FDA reviewers verify establishment registration status during premarket submission review. A lapsed registration can result in a hold or refuse-to-accept action on pending submissions.

Common Mistakes That Cause Missed Renewals

In our consulting practice, we see the same patterns repeatedly. Registration is assigned to a single person who leaves the company with no documented handoff. The FURLS account credentials are lost or tied to a former employee email. Finance and regulatory teams operate in silos, causing fee payment to fall through the cracks. Foreign parent companies assume a U.S. subsidiary is handling it — and vice versa.

The fix is not complicated, but it requires intentional process ownership. Build the October 1 renewal window into your regulatory calendar as a first-priority event, not an administrative afterthought.

A Practical Pre-Renewal Checklist

  • Confirm FURLS account access and update login credentials in a secure shared system
  • Identify all FEI numbers associated with your establishment(s)
  • Pull the current fiscal year fee schedule from FDA.gov and get finance approval in September
  • Audit your device listings for accuracy before submitting renewal
  • Document renewal completion and retain confirmation records for at least two years
  • Calendar a 30-day pre-deadline reminder for October 1 each year

Do Not Let a Procedural Deadline Create a Regulatory Crisis

FDA establishment registration renewal is one of the most straightforward compliance requirements in the device regulatory framework — but it is also one of the most consequential to miss. For startups managing their first commercial launch and mid-size companies with multiple product lines and facilities, the operational risk of a lapsed registration is disproportionate to the effort required to stay current.

At ADB Consulting & CRO Inc., we help medical device companies build regulatory systems that do not depend on institutional memory or heroics. Whether you need a registration audit, help recovering a lapsed registration, or a full regulatory calendar built for your organization, we are here to help you stay ahead of the deadlines that matter.

Book a free discovery call with Andre Butler and the ADB Consulting team at adbccro.com. Let us make sure your registration is locked in before December 31 — and that your regulatory foundation is built to scale.

If this applies to your program, our Device Registration service walks through the process in detail.

Andre Butler

Principal Consultant — ADB Consulting & CRO Inc.

Andre Butler has 20+ years of hands-on FDA regulatory experience guiding medical device companies through 510(k), PMA, De Novo, AI/ML SaMD, and FDA 483 response engagements. He specialises in Section 524B cybersecurity compliance and ISO 13485 quality management systems, with a track record across cardiovascular, orthopedic, diagnostic, and software-as-a-medical-device categories.

Ready to Navigate the FDA Process with Confidence?

Book a free 30-minute discovery call with Andre Butler. No sales pitch -- just expert regulatory guidance on your specific device and situation.

Book a Free Pathway Call

Or call directly: (888) 450-8607

Explore our flat-fee FDA services →